BBHC
BLFS icon

Brown Brothers Harriman & Co’s BioLife Solutions BLFS Stock Holding History

Brown Brothers Harriman & Co’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-235
Closed -$5K – 1307
2022
Q1 		$5K Buy
+235
New +$6.19K ﹤0.01% 1117

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Brown Brothers Harriman & Co's BLFS Position: Q2 2022 in Review

Brown Brothers Harriman & Co sold out of BioLife Solutions (BLFS) in Q2 2022, closing a stake of 235 shares — an estimated $5K sold.

Brown Brothers Harriman & Co first reported a position in BLFS in Q1 2022 and held it in 1 quarter. The position peaked at $5K in Q1 2022. 160 funds tracked by Wall St. Rank hold BLFS as of Q2 2022.

  • Brown Brothers Harriman & Co reported no remaining BioLife Solutions position as of Q2 2022 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 235 BioLife Solutions shares in Q2 2022, an estimated $5K.
  • Brown Brothers Harriman & Co first reported a position in BioLife Solutions in Q1 2022 and held it in 1 quarter.
  • Brown Brothers Harriman & Co's BioLife Solutions position peaked at $5K in Q1 2022.
  • 160 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2022.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2022, filed 11 Aug 2022.